Comments of the Healthcare Supply Chain Association (HSCA) on USTR Request for Comments on the Proposed Modification of Action Pursuant to Section 301
On behalf of the Healthcare Supply Chain Association (HSCA), we appreciate the opportunity to provide comments to the U.S. Trade Representative (USTR) on the proposed modification of action regarding Chinese exports under Section 301.
Click here for the full comments.
Related Posts
HSCA E&C Letter on Improving Competition in the Generic Marketplace
April 1, 2019
Dear Chairman Pallone and Ranking Member Walden, I am writing to you on behalf...
HSCA Statement on FDA Drug Shortages Task Force Report
October 29, 2019
Washington, DC (October 29, 2019) – Healthcare Supply Chain Association (HSCA)...
HSCA Announces 2019 Board of Directors and Names GNYHA Ventures President Lee Perlman Board Chair
January 24, 2019
Washington, DC (January, 2019) – The Healthcare Supply Chain Association (HSCA)...
HSCA Submits Comments to ANSI on Healthcare Supply Chain Data Standards to Help Improve Accuracy, Efficiency, and Patient Safety
November 26, 2019
Washington, DC (November 26, 2019) – The Healthcare Supply Chain Association...